Novel Approaches for Clinical High Risk (CHR) Patient Populations to Prevent Disease Progression
Time: 2:00 pm
day: Day Two
Details:
- A brief history of clinical trials for CHR – Exploring antipsychotic and nonantipsychotic therapies, such as omega fatty acids, to address early symptoms – lessons learned
- Enabling early diagnosis of patients in pre-psychotic states to prevent progression to threshold psychosis, AMP-SCZ
